• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Calendar eNews, DF/HCC's online quarterly newsletter, highlights the groundbreaking research, news, and events taking place within DF/HCC, and showcases the services and tools DF/HCC offers to facilitate collaboration and discovery in the Harvard community.

Welcome to Dana-Farber/Harvard Cancer Center

Welcome to Dana-Farber/Harvard Cancer Center (DF/HCC) — the largest comprehensive cancer center in the world. Funded by a grant from the National Cancer Institute, we have joined seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal — to find new and innovative ways to combat cancer.

Latest Cancer News

    Breast cancer specialist Paula Ryan and basic scientist Leif Ellisen, of MGH, are co-investigators on a phase II trial of cisplatin for triple negative breast cancer.
    Divide-and-conquer strategy drives breast cancer breakthroughs

    Pulling a page from ancient Rome’s military handbook, investigators in the DF/HCC Breast Cancer Program are deploying a divide-and-conquer strategy in the battle against... | [more]

    HER2+ breast cancer cells transfected with siRNAs are grown in the presence or absence of Herceptin for four days. Then cell viability and number are measured.
    siRNA knockdowns turn up intriguing HER2 targets

    At best, only 20 to 30 percent of women with HER2-positive breast cancer respond to trastuzumab. That grim reality has prompted the Breast Cancer Program to search for new... | [more]

    Fusion of renal carcinoma and DCs stained for Cytokeratin (red) and CD86 (blue) 100x.
    Fusion vaccine plus surgery may prove potent combination in renal cell cancer

    Renal cell cancer (RCC) is a life-threatening malignancy considered incurable in the metastatic setting. While standard chemotherapy has proved largely ineffective,... | [more]

    (C–F) RMS cells invade into adjacent muscle (C), intestine (D), liver (E), and kidney (F). Dotted line in D outlines the outer edge of effaced intestine. Arrowheads denote striated muscle tumors. The boxed region in E is a magnified view of a striated cell in the liver. Bars: C–F, 50 µm.
    Specialized Histopathology Services Core

    The Specialized Histopathology Services (SHS) Core provides technical and professional pathology services in a variety of experimental organisms and human tissues. Specific... | [more]